APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary & Animal Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Veterinary & Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchVeterinary & Animal Vaccines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary & Animal Vaccines Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Veterinary & Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary & Animal Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary & Animal Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Veterinary & Animal Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary & Animal Vaccines include Zoetis, Tianjin Ringpu, Merck Animal Health, Virbac, Vetoquinol, Phibro Animal Health, Idt Biologika, Hipra and Hester, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary & Animal Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary & Animal Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary & Animal Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary & Animal Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary & Animal Vaccines Segment by Company

Zoetis

Tianjin Ringpu

Merck Animal Health

Virbac

Vetoquinol

Phibro Animal Health

Idt Biologika

Hipra

Hester

Elanco

China Animal Husbandry

Boehringer Ingelheim

Biogenesis Bago

Veterinary & Animal Vaccines Segment by Type

Live Attenuated Vaccines

Toxoid Vaccines

Inactivated Vaccines

Recombinant Vaccines

Other Vaccines

Veterinary & Animal Vaccines Segment by Application

Hospitals and Clinics

Others

Veterinary & Animal Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary & Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary & Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary & Animal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary & Animal Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary & Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Veterinary & Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Veterinary & Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Veterinary & Animal Vaccines Industry Trends Table 2. Veterinary & Animal Vaccines Industry Drivers Table 3. Veterinary & Animal Vaccines Industry Opportunities and Challenges Table 4. Veterinary & Animal Vaccines Industry Restraints Table 5. Global Veterinary & Animal Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Veterinary & Animal Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Veterinary & Animal Vaccines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Veterinary & Animal Vaccines Sales Market Share by Manufacturers Table 9. Global Veterinary & Animal Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Veterinary & Animal Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Veterinary & Animal Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Veterinary & Animal Vaccines Manufacturers, Product Type & Application Table 13. Global Veterinary & Animal Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary & Animal Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Attenuated Vaccines Table 17. Major Manufacturers of Toxoid Vaccines Table 18. Major Manufacturers of Inactivated Vaccines Table 19. Major Manufacturers of Recombinant Vaccines Table 20. Major Manufacturers of Other Vaccines Table 21. Global Veterinary & Animal Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Veterinary & Animal Vaccines Sales by Type (2021-2026) & (K Units) Table 23. Global Veterinary & Animal Vaccines Sales by Type (2027-2032) & (K Units) Table 24. Global Veterinary & Animal Vaccines Sales Market Share by Type (2021-2026) Table 25. Global Veterinary & Animal Vaccines Sales Market Share by Type (2027-2032) Table 26. Global Veterinary & Animal Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Veterinary & Animal Vaccines Revenue by Type (2021-2026) & (K Units) Table 28. Global Veterinary & Animal Vaccines Revenue by Type (2027-2032) & (K Units) Table 29. Global Veterinary & Animal Vaccines Revenue Market Share by Type (2021-2026) Table 30. Global Veterinary & Animal Vaccines Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospitals and Clinics Table 32. Major Manufacturers of Others Table 33. Global Veterinary & Animal Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Veterinary & Animal Vaccines Sales by Application (2021-2026) & (K Units) Table 35. Global Veterinary & Animal Vaccines Sales by Application (2027-2032) & (K Units) Table 36. Global Veterinary & Animal Vaccines Sales Market Share by Application (2021-2026) Table 37. Global Veterinary & Animal Vaccines Sales Market Share by Application (2027-2032) Table 38. Global Veterinary & Animal Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Veterinary & Animal Vaccines Revenue by Application (2021-2026) & (K Units) Table 40. Global Veterinary & Animal Vaccines Revenue by Application (2027-2032) & (K Units) Table 41. Global Veterinary & Animal Vaccines Revenue Market Share by Application (2021-2026) Table 42. Global Veterinary & Animal Vaccines Revenue Market Share by Application (2027-2032) Table 43. Global Veterinary & Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Veterinary & Animal Vaccines Sales by Region (2021-2026) & (K Units) Table 45. Global Veterinary & Animal Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Veterinary & Animal Vaccines Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Veterinary & Animal Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Veterinary & Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 50. North America Veterinary & Animal Vaccines Sales by Country (2027-2032) & (K Units) Table 51. Europe Veterinary & Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 53. Europe Veterinary & Animal Vaccines Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Veterinary & Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Veterinary & Animal Vaccines Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Veterinary & Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Veterinary & Animal Vaccines Sales by Country (2027-2032) & (K Units) Table 60. Global Veterinary & Animal Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Veterinary & Animal Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Veterinary & Animal Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Veterinary & Animal Vaccines Revenue Market Share by Region (2021-2026) Table 64. Global Veterinary & Animal Vaccines Revenue Market Share by Region (2027-2032) Table 65. Zoetis Company Information Table 66. Zoetis Business Overview Table 67. Zoetis Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Zoetis Veterinary & Animal Vaccines Product Portfolio Table 69. Zoetis Recent Development Table 70. Tianjin Ringpu Company Information Table 71. Tianjin Ringpu Business Overview Table 72. Tianjin Ringpu Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Tianjin Ringpu Veterinary & Animal Vaccines Product Portfolio Table 74. Tianjin Ringpu Recent Development Table 75. Merck Animal Health Company Information Table 76. Merck Animal Health Business Overview Table 77. Merck Animal Health Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merck Animal Health Veterinary & Animal Vaccines Product Portfolio Table 79. Merck Animal Health Recent Development Table 80. Virbac Company Information Table 81. Virbac Business Overview Table 82. Virbac Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Virbac Veterinary & Animal Vaccines Product Portfolio Table 84. Virbac Recent Development Table 85. Vetoquinol Company Information Table 86. Vetoquinol Business Overview Table 87. Vetoquinol Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Vetoquinol Veterinary & Animal Vaccines Product Portfolio Table 89. Vetoquinol Recent Development Table 90. Phibro Animal Health Company Information Table 91. Phibro Animal Health Business Overview Table 92. Phibro Animal Health Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Phibro Animal Health Veterinary & Animal Vaccines Product Portfolio Table 94. Phibro Animal Health Recent Development Table 95. Idt Biologika Company Information Table 96. Idt Biologika Business Overview Table 97. Idt Biologika Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Idt Biologika Veterinary & Animal Vaccines Product Portfolio Table 99. Idt Biologika Recent Development Table 100. Hipra Company Information Table 101. Hipra Business Overview Table 102. Hipra Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Hipra Veterinary & Animal Vaccines Product Portfolio Table 104. Hipra Recent Development Table 105. Hester Company Information Table 106. Hester Business Overview Table 107. Hester Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Hester Veterinary & Animal Vaccines Product Portfolio Table 109. Hester Recent Development Table 110. Elanco Company Information Table 111. Elanco Business Overview Table 112. Elanco Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Elanco Veterinary & Animal Vaccines Product Portfolio Table 114. Elanco Recent Development Table 115. China Animal Husbandry Company Information Table 116. China Animal Husbandry Business Overview Table 117. China Animal Husbandry Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. China Animal Husbandry Veterinary & Animal Vaccines Product Portfolio Table 119. China Animal Husbandry Recent Development Table 120. Boehringer Ingelheim Company Information Table 121. Boehringer Ingelheim Business Overview Table 122. Boehringer Ingelheim Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Boehringer Ingelheim Veterinary & Animal Vaccines Product Portfolio Table 124. Boehringer Ingelheim Recent Development Table 125. Biogenesis Bago Company Information Table 126. Biogenesis Bago Business Overview Table 127. Biogenesis Bago Veterinary & Animal Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Biogenesis Bago Veterinary & Animal Vaccines Product Portfolio Table 129. Biogenesis Bago Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Veterinary & Animal Vaccines Distributors List Table 133. Veterinary & Animal Vaccines Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Veterinary & Animal Vaccines Product Image Figure 2. Global Veterinary & Animal Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary & Animal Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary & Animal Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Veterinary & Animal Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Veterinary & Animal Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Attenuated Vaccines Image Figure 9. Toxoid Vaccines Image Figure 10. Inactivated Vaccines Image Figure 11. Recombinant Vaccines Image Figure 12. Other Vaccines Image Figure 13. Global Veterinary & Animal Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Veterinary & Animal Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary & Animal Vaccines Sales Market Share by Type (2021-2032) Figure 16. Global Veterinary & Animal Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Veterinary & Animal Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Veterinary & Animal Vaccines Revenue Market Share by Type (2021-2032) Figure 19. Hospitals and Clinics Image Figure 20. Others Image Figure 21. Global Veterinary & Animal Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Veterinary & Animal Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Veterinary & Animal Vaccines Sales Market Share by Application (2021-2032) Figure 24. Global Veterinary & Animal Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Veterinary & Animal Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Veterinary & Animal Vaccines Revenue Market Share by Application (2021-2032) Figure 27. North America Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Veterinary & Animal Vaccines Sales Market Share by Country (2021-2032) Figure 29. U.S. Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Veterinary & Animal Vaccines Sales Market Share by Country (2021-2032) Figure 34. Germany Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Veterinary & Animal Vaccines Sales Market Share by Country (2021-2032) Figure 41. China Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Veterinary & Animal Vaccines Sales Market Share by Country (2021-2032) Figure 49. Brazil Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Veterinary & Animal Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Veterinary & Animal Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Veterinary & Animal Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Veterinary & Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. North America Veterinary & Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Veterinary & Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Europe Veterinary & Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Veterinary & Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Veterinary & Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Veterinary & Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Veterinary & Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Veterinary & Animal Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Veterinary & Animal Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Other Vaccines
Applications
  • Hospitals and Clinics
  • Others
Companies covered
  • Zoetis
  • Tianjin Ringpu
  • Merck Animal Health
  • Virbac
  • Vetoquinol
  • Phibro Animal Health
  • Idt Biologika
  • Hipra
  • Hester
  • Elanco
  • China Animal Husbandry
  • Boehringer Ingelheim
  • Biogenesis Bago

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary & Animal Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary & Animal Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Veterinary & Animal Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Veterinary & Animal Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Veterinary & Animal Vaccines Market Dynamics
  1. 2.1 Veterinary & Animal Vaccines Industry Trends
  2. 2.2 Veterinary & Animal Vaccines Industry Drivers
  3. 2.3 Veterinary & Animal Vaccines Industry Opportunities and Challenges
  4. 2.4 Veterinary & Animal Vaccines Industry Restraints
3 Veterinary & Animal Vaccines Market by Manufacturers
  1. 3.1 Global Veterinary & Animal Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Veterinary & Animal Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Veterinary & Animal Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Veterinary & Animal Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary & Animal Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Veterinary & Animal Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Veterinary & Animal Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary & Animal Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary & Animal Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary & Animal Vaccines Tier 1, Tier 2, and Tier 3
4 Veterinary & Animal Vaccines Market by Type
  1. 4.1 Veterinary & Animal Vaccines Type Introduction
  2. 4.1.1 Live Attenuated Vaccines
  3. 4.1.2 Toxoid Vaccines
  4. 4.1.3 Inactivated Vaccines
  5. 4.1.4 Recombinant Vaccines
  6. 4.1.5 Other Vaccines
  7. 4.2 Global Veterinary & Animal Vaccines Sales by Type
  8. 4.2.1 Global Veterinary & Animal Vaccines Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Veterinary & Animal Vaccines Sales by Type (2021-2032)
  10. 4.2.3 Global Veterinary & Animal Vaccines Sales Market Share by Type (2021-2032)
  11. 4.3 Global Veterinary & Animal Vaccines Revenue by Type
  12. 4.3.1 Global Veterinary & Animal Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Veterinary & Animal Vaccines Revenue by Type (2021-2032)
  14. 4.3.3 Global Veterinary & Animal Vaccines Revenue Market Share by Type (2021-2032)
5 Veterinary & Animal Vaccines Market by Application
  1. 5.1 Veterinary & Animal Vaccines Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Others
  4. 5.2 Global Veterinary & Animal Vaccines Sales by Application
  5. 5.2.1 Global Veterinary & Animal Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary & Animal Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Veterinary & Animal Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Veterinary & Animal Vaccines Revenue by Application
  9. 5.3.1 Global Veterinary & Animal Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Veterinary & Animal Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Veterinary & Animal Vaccines Revenue Market Share by Application (2021-2032)
6 Global Veterinary & Animal Vaccines Sales by Region
  1. 6.1 Global Veterinary & Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary & Animal Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary & Animal Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Veterinary & Animal Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary & Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Veterinary & Animal Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Veterinary & Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Veterinary & Animal Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Veterinary & Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Veterinary & Animal Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Veterinary & Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Veterinary & Animal Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Veterinary & Animal Vaccines Revenue by Region
  1. 7.1 Global Veterinary & Animal Vaccines Revenue by Region
  2. 7.1.1 Global Veterinary & Animal Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Veterinary & Animal Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Veterinary & Animal Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Veterinary & Animal Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Veterinary & Animal Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Veterinary & Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Veterinary & Animal Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Veterinary & Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Veterinary & Animal Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Veterinary & Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Veterinary & Animal Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Veterinary & Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Veterinary & Animal Vaccines Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Tianjin Ringpu
  8. 8.2.1 Tianjin Ringpu Company Information
  9. 8.2.2 Tianjin Ringpu Business Overview
  10. 8.2.3 Tianjin Ringpu Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tianjin Ringpu Veterinary & Animal Vaccines Product Portfolio
  12. 8.2.5 Tianjin Ringpu Recent Developments
  13. 8.3 Merck Animal Health
  14. 8.3.1 Merck Animal Health Company Information
  15. 8.3.2 Merck Animal Health Business Overview
  16. 8.3.3 Merck Animal Health Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Veterinary & Animal Vaccines Product Portfolio
  18. 8.3.5 Merck Animal Health Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Veterinary & Animal Vaccines Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Vetoquinol
  26. 8.5.1 Vetoquinol Company Information
  27. 8.5.2 Vetoquinol Business Overview
  28. 8.5.3 Vetoquinol Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol Veterinary & Animal Vaccines Product Portfolio
  30. 8.5.5 Vetoquinol Recent Developments
  31. 8.6 Phibro Animal Health
  32. 8.6.1 Phibro Animal Health Company Information
  33. 8.6.2 Phibro Animal Health Business Overview
  34. 8.6.3 Phibro Animal Health Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Phibro Animal Health Veterinary & Animal Vaccines Product Portfolio
  36. 8.6.5 Phibro Animal Health Recent Developments
  37. 8.7 Idt Biologika
  38. 8.7.1 Idt Biologika Company Information
  39. 8.7.2 Idt Biologika Business Overview
  40. 8.7.3 Idt Biologika Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Idt Biologika Veterinary & Animal Vaccines Product Portfolio
  42. 8.7.5 Idt Biologika Recent Developments
  43. 8.8 Hipra
  44. 8.8.1 Hipra Company Information
  45. 8.8.2 Hipra Business Overview
  46. 8.8.3 Hipra Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hipra Veterinary & Animal Vaccines Product Portfolio
  48. 8.8.5 Hipra Recent Developments
  49. 8.9 Hester
  50. 8.9.1 Hester Company Information
  51. 8.9.2 Hester Business Overview
  52. 8.9.3 Hester Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hester Veterinary & Animal Vaccines Product Portfolio
  54. 8.9.5 Hester Recent Developments
  55. 8.10 Elanco
  56. 8.10.1 Elanco Company Information
  57. 8.10.2 Elanco Business Overview
  58. 8.10.3 Elanco Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Elanco Veterinary & Animal Vaccines Product Portfolio
  60. 8.10.5 Elanco Recent Developments
  61. 8.11 China Animal Husbandry
  62. 8.11.1 China Animal Husbandry Company Information
  63. 8.11.2 China Animal Husbandry Business Overview
  64. 8.11.3 China Animal Husbandry Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 China Animal Husbandry Veterinary & Animal Vaccines Product Portfolio
  66. 8.11.5 China Animal Husbandry Recent Developments
  67. 8.12 Boehringer Ingelheim
  68. 8.12.1 Boehringer Ingelheim Company Information
  69. 8.12.2 Boehringer Ingelheim Business Overview
  70. 8.12.3 Boehringer Ingelheim Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Boehringer Ingelheim Veterinary & Animal Vaccines Product Portfolio
  72. 8.12.5 Boehringer Ingelheim Recent Developments
  73. 8.13 Biogenesis Bago
  74. 8.13.1 Biogenesis Bago Company Information
  75. 8.13.2 Biogenesis Bago Business Overview
  76. 8.13.3 Biogenesis Bago Veterinary & Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biogenesis Bago Veterinary & Animal Vaccines Product Portfolio
  78. 8.13.5 Biogenesis Bago Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary & Animal Vaccines Value Chain Analysis
  2. 9.1.1 Veterinary & Animal Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary & Animal Vaccines Production Mode & Process
  6. 9.2 Veterinary & Animal Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary & Animal Vaccines Distributors
  9. 9.2.3 Veterinary & Animal Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst